(Alliance News) - Oxford Nanopore Technologies PLC shares surged on Friday as it set out upbeat guidance for the full-year. The Oxford-based specialist in DNA and RNA sequencing technologies said 2025 ...
Simply put, Illumina tends to have better profitability ratios compared to its peers. For instance, Illumina has a 68.38% ...
Turkish immigrant Oguzhan Atay started the company in 2016 with a focus on prenatal testing. Now, he’s expanding to cancer ...
DNA isn't just a long string of genetic code, but an intricate 3D structure folded inside each cell. That means the tools ...
China is set to ease restrictions on some Illumina products, giving the sequencing giant a partial reprieve. | China is set to ease restrictions on some Illumina products, giving the sequencing giant ...
Tier 1 aberrations, which are classified as those having well-established prognostic, diagnostic, or therapeutic relevance according to guidelines set by medical societies such as WHO, NCCN and ICC, ...
Oxford Nanopore is moving ahead with plans for an initial public offering (IPO) and has now hired banks to manage the process, two sources familiar with the matter told Reuters, in a further boost to ...
Illumina Inc. said the Chinese government has lifted a ban on the company selling its DNA sequencing machines inside the country.
At the booth of Gilead Sciences, Lenacapavir, to be used as the world's only twice-yearly, long-acting injectable for HIV ...
“PacBio’s mission is to enable the promise of genomics to better human health,” said Christian Henry, President and Chief Executive Officer of PacBio. “China’s regulatory approval of Sequel II CNDx ...
New scientific article warns of loss of consumer trust unless proper analysis is done. Report: Claire Robinson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback